Abzena takes modular approach to biologics suites

This expansion has been driven by an increase in customer demand for commercial-scale 2000L single-use bioreactors across a wide range of therapeutic areas

picture of

Breaking News

Celonic to boost ATMP production at upcoming Swiss life science park

The CDMO has planned a two-phase expansion of a facility, adding up to 20 GMP cleanroom suites and offices along with ...

Cytiva works with Indian state on biopharma scale-up facility

The city of Hyderabad in Telangana is well-positioned to host the 10,000 sqft lab, which will be located in the Genome ...

Samsung Bioepis opens Korea HQ for biologics

The building was completed in December 2020

Space travel puts mitochondria’s central role in the spotlight

The scientific community has long validated the significance of mitochondria as our cell’s “energy factories.” ...

Thermo Fisher acquires viral vector manufacturing business from Novasep

The business will be part of the pharma services business within the laboratory products and services segment

Abzena takes modular approach to biologics suites

This expansion has been driven by an increase in customer demand for commercial-scale 2000L single-use bioreactors ...

From dark art to an age of enlightenment

Much is happening in the realms of Almac’s GMP peptides business in terms of growth, development and strategic ...

Nanoform and Herantis partner

The companies will look for opportunities to enhance BBB penetration of CDNF and xCDNF molecules

WHP completes viral vector manufacturing centre for Oxford Biomedica

The centre is being used for the worldwide manufacture and distribution of the COVID-19 vaccine by AstraZeneca

Expanding the medicinal chemist’s toolbox

Ray Boffey, Executive Director of Medicines Research at Domainex, explains the applications and benefits of fragment- ...

The application of picodroplet technology for biopharmaceutical discovery and scientific research

Picodroplet technologies continue to push the boundaries of biologic discovery by accelerating research, expanding the ...

The business and patient case for drug delivery device innovation in biosimilar products

Biosimilar development in the United States is at an important juncture, reports Darren Mansell, Regulatory Affairs ...

EVerZom raises $1.3m to industrialise exosome biomanufacturing platform

This funding will speed up the platform development and scale-up, with the objective to allow routine clinical grade ...

Watson-Marlow to open ISO 14644-1 Class 7 cleanroom

The facility at the site in Cork is currently in development and will be validated to ISO 9001 Quality Management ...